Is SNWV or IRIX more profitable?

Sanuwave Health has a net margin of 35.96% compared to IRIDEX's net margin of -6.23%. IRIDEX's return on equity of 0.00% beat Sanuwave Health's return on equity. Company Net Margins Return on Equity Return on Assets Sanuwave Health 35.96% -450.56% 44.87% IRIDEX -6.23% N/A -11.16%

Which has stronger valuation and earnings, LNSR or IRIX?

IRIDEX has lower revenue, but higher earnings than LENSAR. LENSAR is trading at a lower price-to-earnings ratio than IRIDEX, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio LENSAR $58.44M 1.29 -$34.28M -$0.58 N/A IRIDEX $52.67M 0.37 -$4.44M -$0.19 N/A

Is LNSR or IRIX more profitable?

LENSAR has a net margin of 50.94% compared to IRIDEX's net margin of -6.23%. IRIDEX's return on equity of 0.00% beat LENSAR's return on equity. Company Net Margins Return on Equity Return on Assets LENSAR 50.94% -183.19% 42.26% IRIDEX -6.23% N/A -11.16%

Do analysts rate IRIX or AGPU?

IRIDEX presently has a consensus price target of $3.00, indicating a potential upside of 166.43%. Given IRIDEX's stronger consensus rating and higher probable upside, research analysts plainly believe IRIDEX is more favorable than Predictive Oncology. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IRIDEX 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Predictive Oncology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings & valuation, IRIX or AGPU?

IRIDEX has higher revenue and earnings than Predictive Oncology. IRIDEX is trading at a lower price-to-earnings ratio than Predictive Oncology, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IRIDEX $52.67M 0.37 -$4.44M -$0.19 N/A Predictive Oncology $50.29K 1,528.67 -$233.10M -$8.18 N/A

Is IRIX or AGPU more profitable?

IRIDEX has a net margin of -6.23% compared to Predictive Oncology's net margin of -470,383.31%. IRIDEX's return on equity of 0.00% beat Predictive Oncology's return on equity. Company Net Margins Return on Equity Return on Assets IRIDEX -6.23% N/A -11.16% Predictive Oncology -470,383.31% -7,363.67% -626.32%

Which has higher valuation & earnings, ECOR or IRIX?

IRIDEX has higher revenue and earnings than electroCore. IRIDEX is trading at a lower price-to-earnings ratio than electroCore, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio electroCore $34.90M 2.00 -$13.97M -$1.77 N/A IRIDEX $52.67M 0.37 -$4.44M -$0.19 N/A

Is ECOR or IRIX more profitable?

IRIDEX has a net margin of -6.23% compared to electroCore's net margin of -44.08%. IRIDEX's return on equity of 0.00% beat electroCore's return on equity. Company Net Margins Return on Equity Return on Assets electroCore -44.08% -1,956.38% -83.30% IRIDEX -6.23% N/A -11.16%

Do analysts prefer IRIX or IINN?

IRIDEX presently has a consensus price target of $3.00, indicating a potential upside of 166.43%. Given IRIDEX's stronger consensus rating and higher possible upside, analysts clearly believe IRIDEX is more favorable than Inspira Technologies OXY B.H.N.. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IRIDEX 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Inspira Technologies OXY B.H.N. 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings & valuation, IRIX or IINN?

IRIDEX has higher revenue and earnings than Inspira Technologies OXY B.H.N.. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IRIDEX $52.67M 0.37 -$4.44M -$0.19 N/A Inspira Technologies OXY B.H.N. $289K 187.83 -$13.22M N/A N/A

Is IRIX or IINN more profitable?

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to IRIDEX's net margin of -6.23%. Company Net Margins Return on Equity Return on Assets IRIDEX -6.23% N/A -11.16% Inspira Technologies OXY B.H.N. N/A N/A N/A

IRIDEX (IRIX) Competitors

$1.13 -0.04 (-3.42%)

As of 02:30 PM Eastern

Compare

IRIX vs. SNWV, LNSR, AGPU, ECOR, and IINN

Should you buy IRIDEX stock or one of its competitors? MarketBeat compares IRIDEX with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with IRIDEX include Sanuwave Health (SNWV), LENSAR (LNSR), Predictive Oncology (AGPU), electroCore (ECOR), and Inspira Technologies OXY B.H.N. (IINN). These companies are all part of the "medical equipment" industry.

How does IRIDEX compare to Sanuwave Health?

Sanuwave Health (NASDAQ:SNWV) and IRIDEX (NASDAQ:IRIX) are both small-cap medical equipment companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, risk, institutional ownership, profitability, analyst recommendations, valuation and dividends.

Sanuwave Health has a net margin of 35.96% compared to IRIDEX's net margin of -6.23%. IRIDEX's return on equity of 0.00% beat Sanuwave Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sanuwave Health	35.96%	-450.56%	44.87%
IRIDEX	-6.23%	N/A	-11.16%

Sanuwave Health currently has a consensus price target of $51.00, suggesting a potential upside of 396.40%. IRIDEX has a consensus price target of $3.00, suggesting a potential upside of 166.43%. Given Sanuwave Health's stronger consensus rating and higher probable upside, analysts plainly believe Sanuwave Health is more favorable than IRIDEX.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sanuwave Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Sanuwave Health has higher earnings, but lower revenue than IRIDEX. IRIDEX is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sanuwave Health	$44.05M	2.01	$11.81M	$0.33	31.13
IRIDEX	$52.67M	0.37	-$4.44M	-$0.19	N/A

In the previous week, Sanuwave Health had 3 more articles in the media than IRIDEX. MarketBeat recorded 4 mentions for Sanuwave Health and 1 mentions for IRIDEX. IRIDEX's average media sentiment score of 1.32 beat Sanuwave Health's score of 0.47 indicating that IRIDEX is being referred to more favorably in the news media.

Company	Overall Sentiment
Sanuwave Health	Neutral
IRIDEX	Positive

Sanuwave Health has a beta of 1.42, suggesting that its stock price is 42% more volatile than the broader market. Comparatively, IRIDEX has a beta of 0.63, suggesting that its stock price is 37% less volatile than the broader market.

42.5% of Sanuwave Health shares are owned by institutional investors. Comparatively, 20.1% of IRIDEX shares are owned by institutional investors. 14.4% of Sanuwave Health shares are owned by insiders. Comparatively, 8.6% of IRIDEX shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Sanuwave Health beats IRIDEX on 13 of the 16 factors compared between the two stocks.

How does IRIDEX compare to LENSAR?

LENSAR (NASDAQ:LNSR) and IRIDEX (NASDAQ:IRIX) are both small-cap medical equipment companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability, valuation and media sentiment.

40.2% of LENSAR shares are owned by institutional investors. Comparatively, 20.1% of IRIDEX shares are owned by institutional investors. 65.8% of LENSAR shares are owned by company insiders. Comparatively, 8.6% of IRIDEX shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

LENSAR presently has a consensus price target of $10.00, suggesting a potential upside of 62.36%. IRIDEX has a consensus price target of $3.00, suggesting a potential upside of 166.43%. Given IRIDEX's higher probable upside, analysts clearly believe IRIDEX is more favorable than LENSAR.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LENSAR	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

LENSAR has a net margin of 50.94% compared to IRIDEX's net margin of -6.23%. IRIDEX's return on equity of 0.00% beat LENSAR's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LENSAR	50.94%	-183.19%	42.26%
IRIDEX	-6.23%	N/A	-11.16%

IRIDEX has lower revenue, but higher earnings than LENSAR. LENSAR is trading at a lower price-to-earnings ratio than IRIDEX, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LENSAR	$58.44M	1.29	-$34.28M	-$0.58	N/A
IRIDEX	$52.67M	0.37	-$4.44M	-$0.19	N/A

In the previous week, LENSAR and LENSAR both had 1 articles in the media. LENSAR's average media sentiment score of 1.89 beat IRIDEX's score of 1.32 indicating that LENSAR is being referred to more favorably in the media.

Company	Overall Sentiment
LENSAR	Very Positive
IRIDEX	Positive

LENSAR has a beta of 0.87, indicating that its stock price is 13% less volatile than the broader market. Comparatively, IRIDEX has a beta of 0.63, indicating that its stock price is 37% less volatile than the broader market.

Summary

LENSAR beats IRIDEX on 10 of the 15 factors compared between the two stocks.

How does IRIDEX compare to Predictive Oncology?

IRIDEX (NASDAQ:IRIX) and Predictive Oncology (NASDAQ:AGPU) are both small-cap medical equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, profitability, media sentiment, institutional ownership and valuation.

IRIDEX presently has a consensus price target of $3.00, indicating a potential upside of 166.43%. Given IRIDEX's stronger consensus rating and higher probable upside, research analysts plainly believe IRIDEX is more favorable than Predictive Oncology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Predictive Oncology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

20.1% of IRIDEX shares are owned by institutional investors. Comparatively, 9.0% of Predictive Oncology shares are owned by institutional investors. 8.6% of IRIDEX shares are owned by company insiders. Comparatively, 1.2% of Predictive Oncology shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

IRIDEX has a net margin of -6.23% compared to Predictive Oncology's net margin of -470,383.31%. IRIDEX's return on equity of 0.00% beat Predictive Oncology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IRIDEX	-6.23%	N/A	-11.16%
Predictive Oncology	-470,383.31%	-7,363.67%	-626.32%

IRIDEX has a beta of 0.63, suggesting that its stock price is 37% less volatile than the broader market. Comparatively, Predictive Oncology has a beta of 3.43, suggesting that its stock price is 243% more volatile than the broader market.

In the previous week, Predictive Oncology had 1 more articles in the media than IRIDEX. MarketBeat recorded 2 mentions for Predictive Oncology and 1 mentions for IRIDEX. IRIDEX's average media sentiment score of 1.32 beat Predictive Oncology's score of 0.93 indicating that IRIDEX is being referred to more favorably in the media.

Company	Overall Sentiment
IRIDEX	Positive
Predictive Oncology	Positive

IRIDEX has higher revenue and earnings than Predictive Oncology. IRIDEX is trading at a lower price-to-earnings ratio than Predictive Oncology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IRIDEX	$52.67M	0.37	-$4.44M	-$0.19	N/A
Predictive Oncology	$50.29K	1,528.67	-$233.10M	-$8.18	N/A

Summary

IRIDEX beats Predictive Oncology on 12 of the 16 factors compared between the two stocks.

How does IRIDEX compare to electroCore?

electroCore (NASDAQ:ECOR) and IRIDEX (NASDAQ:IRIX) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, valuation, media sentiment, analyst recommendations, profitability, earnings, dividends and institutional ownership.

IRIDEX has a net margin of -6.23% compared to electroCore's net margin of -44.08%. IRIDEX's return on equity of 0.00% beat electroCore's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
electroCore	-44.08%	-1,956.38%	-83.30%
IRIDEX	-6.23%	N/A	-11.16%

electroCore currently has a consensus target price of $18.00, indicating a potential upside of 113.68%. IRIDEX has a consensus target price of $3.00, indicating a potential upside of 166.43%. Given IRIDEX's higher probable upside, analysts clearly believe IRIDEX is more favorable than electroCore.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
electroCore	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, electroCore and electroCore both had 1 articles in the media. electroCore's average media sentiment score of 1.89 beat IRIDEX's score of 1.32 indicating that electroCore is being referred to more favorably in the media.

Company	Overall Sentiment
electroCore	Very Positive
IRIDEX	Positive

IRIDEX has higher revenue and earnings than electroCore. IRIDEX is trading at a lower price-to-earnings ratio than electroCore, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
electroCore	$34.90M	2.00	-$13.97M	-$1.77	N/A
IRIDEX	$52.67M	0.37	-$4.44M	-$0.19	N/A

electroCore has a beta of 0.88, suggesting that its stock price is 12% less volatile than the broader market. Comparatively, IRIDEX has a beta of 0.63, suggesting that its stock price is 37% less volatile than the broader market.

26.7% of electroCore shares are owned by institutional investors. Comparatively, 20.1% of IRIDEX shares are owned by institutional investors. 13.8% of electroCore shares are owned by insiders. Comparatively, 8.6% of IRIDEX shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

IRIDEX beats electroCore on 7 of the 13 factors compared between the two stocks.

How does IRIDEX compare to Inspira Technologies OXY B.H.N.?

IRIDEX (NASDAQ:IRIX) and Inspira Technologies OXY B.H.N. (NASDAQ:IINN) are both small-cap medical equipment companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, media sentiment, dividends, risk, profitability and institutional ownership.

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to IRIDEX's net margin of -6.23%.

Company	Net Margins	Return on Equity	Return on Assets
IRIDEX	-6.23%	N/A	-11.16%
Inspira Technologies OXY B.H.N.	N/A	N/A	N/A

In the previous week, IRIDEX and IRIDEX both had 1 articles in the media. IRIDEX's average media sentiment score of 1.32 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that IRIDEX is being referred to more favorably in the media.

Company	Overall Sentiment
IRIDEX	Positive
Inspira Technologies OXY B.H.N.	Neutral

IRIDEX has a beta of 0.63, meaning that its share price is 37% less volatile than the broader market. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 2.16, meaning that its share price is 116% more volatile than the broader market.

IRIDEX has higher revenue and earnings than Inspira Technologies OXY B.H.N..

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IRIDEX	$52.67M	0.37	-$4.44M	-$0.19	N/A
Inspira Technologies OXY B.H.N.	$289K	187.83	-$13.22M	N/A	N/A

20.1% of IRIDEX shares are owned by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. 8.6% of IRIDEX shares are owned by company insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

IRIDEX presently has a consensus price target of $3.00, indicating a potential upside of 166.43%. Given IRIDEX's stronger consensus rating and higher possible upside, analysts clearly believe IRIDEX is more favorable than Inspira Technologies OXY B.H.N..

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Inspira Technologies OXY B.H.N.	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

IRIDEX beats Inspira Technologies OXY B.H.N. on 7 of the 12 factors compared between the two stocks.

Get IRIDEX News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IRIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IRIX vs. The Competition

Export

Metric	IRIDEX	LASERS Industry	Computer Sector	NASDAQ Exchange
Market Cap	$19.60M	$702.59M	$37.69B	$12.31B
Dividend Yield	N/A	N/A	3.32%	6.14%
P/E Ratio	-5.93	38.01	78.25	24.84
Price / Sales	0.37	149.22	614.03	98.66
Price / Cash	N/A	43.79	48.34	59.26
Price / Book	-18.77	15.92	9.54	6.44
Net Income	-$4.44M	-$16.97M	$1.07B	$336.71M
7 Day Performance	-4.58%	2.59%	1.89%	2.17%
1 Month Performance	-3.76%	-8.44%	-4.19%	-0.11%
1 Year Performance	23.71%	-8.39%	145.69%	24.91%

IRIDEX Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IRIX IRIDEX	2.6554 of 5 stars	$1.13 -3.4%	$3.00 +165.5%	+31.4%	$19.67M	$52.67M	N/A	120
SNWV Sanuwave Health	2.2038 of 5 stars	$8.95 +9.1%	$51.00 +470.2%	-67.1%	$76.96M	$44.34M	27.12	40	News Coverage
LNSR LENSAR	1.6875 of 5 stars	$6.01 +5.0%	$10.00 +66.5%	-54.3%	$72.69M	$57.70M	N/A	110
AGPU Predictive Oncology	0.6024 of 5 stars	$6.37 -3.4%	N/A	N/A	$68.87M	$120K	N/A	30	Analyst Upgrade
ECOR electroCore	3.8827 of 5 stars	$8.28 -0.9%	$18.00 +117.5%	+58.4%	$68.68M	$32.03M	N/A	50

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:IRIX) was last updated on 7/2/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

IRIDEX (IRIX) Competitors

IRIX vs. SNWV, LNSR, AGPU, ECOR, and IINN

How does IRIDEX compare to Sanuwave Health?

Summary

How does IRIDEX compare to LENSAR?

Summary

How does IRIDEX compare to Predictive Oncology?

Summary

How does IRIDEX compare to electroCore?

Summary

How does IRIDEX compare to Inspira Technologies OXY B.H.N.?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IRIX vs. The Competition

IRIDEX Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

IRIDEX (IRIX) Competitors

IRIX vs. SNWV, LNSR, AGPU, ECOR, and IINN

How does IRIDEX compare to Sanuwave Health?

Is SNWV or IRIX more profitable?

Do analysts recommend SNWV or IRIX?

Which has stronger earnings & valuation, SNWV or IRIX?

Does the media prefer SNWV or IRIX?

Which has more volatility and risk, SNWV or IRIX?

Do institutionals & insiders have more ownership in SNWV or IRIX?

Summary

How does IRIDEX compare to LENSAR?

Do institutionals and insiders have more ownership in LNSR or IRIX?

Do analysts recommend LNSR or IRIX?

Is LNSR or IRIX more profitable?

Which has stronger valuation and earnings, LNSR or IRIX?

Does the media refer more to LNSR or IRIX?

Which has more risk and volatility, LNSR or IRIX?

Summary

How does IRIDEX compare to Predictive Oncology?

Do analysts rate IRIX or AGPU?

Do insiders & institutionals believe in IRIX or AGPU?

Is IRIX or AGPU more profitable?

Which has more risk and volatility, IRIX or AGPU?

Does the media favor IRIX or AGPU?

Which has stronger earnings & valuation, IRIX or AGPU?

Summary

How does IRIDEX compare to electroCore?

Is ECOR or IRIX more profitable?

Do analysts rate ECOR or IRIX?

Does the media refer more to ECOR or IRIX?

Which has higher valuation & earnings, ECOR or IRIX?

Which has more volatility and risk, ECOR or IRIX?

Do insiders and institutionals believe in ECOR or IRIX?

Summary

How does IRIDEX compare to Inspira Technologies OXY B.H.N.?

Is IRIX or IINN more profitable?

Does the media favor IRIX or IINN?

Which has more volatility and risk, IRIX or IINN?

Which has higher earnings & valuation, IRIX or IINN?

Do institutionals & insiders hold more shares of IRIX or IINN?

Do analysts prefer IRIX or IINN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IRIX vs. The Competition

IRIDEX Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools